Ball's Tetrous Expands with New Zealand Distribution for Innovative EnFix® Implants
- Tetrous, Inc. partners with Alpha Medical for exclusive distribution of EnFix® implants in New Zealand.
- Dr. Craig Ball joins Tetrous' Clinical Advisory Board to advocate for EnFix in rotator cuff surgeries.
- The collaboration aims to enhance orthopedic care and improve patient recovery using innovative biologic solutions.
Tetrous, Inc. Expands Its Reach with New Zealand Distribution Agreement
Tetrous, Inc., a Sherman Oaks-based startup focused on bone-to-tendon healing post-orthopedic surgeries, solidifies its expansion into New Zealand through a newly signed distribution agreement with Alpha Medical. This partnership marks a significant milestone for Tetrous, which has already established a presence in the U.S. and Australia, where its innovative products are commercialized via Australian Biotechnologies. The agreement grants Alpha Medical exclusive distribution rights for Tetrous' EnFix® demineralized bone fiber implants, which are designed specifically for enthesis repair across various joints, including the shoulder, elbow, hip, knee, and ankle.
The EnFix implant represents a breakthrough in orthopedic treatment, targeting the critical healing process following surgery. John Bojanowski, Chief Commercial Officer at Tetrous, expresses optimism about the collaboration with Alpha Medical, praising their extensive experience with biologic products and their shared commitment to enhancing patient outcomes. This partnership not only broadens Tetrous' market reach but also aligns with its mission to provide advanced surgical solutions that improve recovery times and outcomes for orthopedic patients.
Furthermore, the strategic collaboration anticipates valuable contributions from Dr. Craig Ball, a prominent shoulder surgeon in New Zealand, who joins Tetrous' Clinical Advisory Board. Dr. Ball is keen to utilize the EnFix product at Southern Cross Healthcare – Brightside Hospital in Auckland, emphasizing the importance of biologic augmentation for rotator cuff surgeries. His involvement signals a strong endorsement of the product's potential to facilitate healing and expedite recovery for patients. Meanwhile, Brandon Hiini, CEO of Alpha Medical, echoes this sentiment, highlighting the alignment of Tetrous' innovative solutions with their mission to support healthcare professionals and enhance patient care in New Zealand.
In addition to the distribution agreement, the collaboration between Tetrous and Alpha Medical is poised to set a new standard for orthopedic care in the region. By leveraging advanced technologies like the EnFix implant, healthcare providers can improve surgical outcomes and patient experiences significantly. This partnership underscores the growing trend of incorporating biologic materials in orthopedic procedures, aimed at fostering better recovery and rehabilitation for patients.
Related Cashu News

Quaker Houghton Expands Operations in China to Boost Manufacturing and Market Presence
Quaker Houghton (Ticker: KWR) is advancing its operational footprint with the opening of a new manufacturing facility in Zhangjiagang, China, alongside the expansion of its laboratory in Shanghai. The…

FMC Corporation Partners with Tessenderlo Group to Enhance Market Position and Innovation
FMC Corporation (Ticker: FMC) announces a significant strategic maneuver as it makes strides in enhancing its market positioning through a prominent investment from Tessenderlo Group. This partnership…

International Paper Restructures Operations, Closes Four Plants for Enhanced Efficiency and Sustainability
International Paper Company (Ticker: IP) actively reshapes its operational strategy to enhance efficiency and sustainability within its North American network. The company announces significant change…

Air Products Shifts Focus to Renewable Ammonia Post Project Cancellations and Financial Setbacks
Air Products & Chemicals (Ticker: APD) pivots towards renewable ammonia amidst project cancellations. Air Products Scraps Louisiana Clean Energy Complex The company announces it will not continue with…

